TRIB
Trinity Biotech
TRIB
TRIB
20 hedge funds and large institutions have $5.96M invested in Trinity Biotech in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $6.51M → $5.96M (-$550K)
71% less call options, than puts
Call options by funds: $5K | Put options by funds: $17K
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
20
Holding in Top 10
1
Calls
$5K
Puts
$17K
Top Buyers
| 1 | +$20.9K | |
| 2 | +$13.8K | |
| 3 | +$10.9K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$14 |
Top Sellers
| 1 | -$79.6K | |
| 2 | -$53.8K | |
| 3 | -$50.4K | |
| 4 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
-$46K |
| 5 |
LPL Financial
San Diego,
California
|
-$25.7K |